BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30
• 31

• Roper Technologies Prices Public Offering Of $600 Million Senior Unsecured Notes Due 2020 And $300 Million Senior Unsecured Notes Due 2025

  December 1, 2015

   · 

  4 min read
• Business

  Sunshine Heart CEO to Step Down

  December 1, 2015

   · 

  3 min read
• Drug Development

  CytoDyn Release: Eleven HIV Patients Successfully Reach One Year Of Full Virologic Suppression In Pro 140 Monotherapy Phase IIb Extension Study

  December 1, 2015

   · 

  7 min read
• Business

  Radient Technologies Inc. Announces Release Of Financial Results For Its Second Quarter Ended March 31, 2016

  December 1, 2015

   · 

  2 min read
• Drug Development

  CardioCell Plans Phase IIb Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure

  December 1, 2015

   · 

  5 min read
• BioCapital

  Spherix Moves Forward with Numerous Opportunities After Licensing Agreement

  December 1, 2015

   · 

  3 min read
• Business

  Heat Biologics Appoints Timothy Creech As Chief Financial Officer

  December 1, 2015

   · 

  3 min read
• BioMidwest

  American Brain Tumor Association Announces Two Research Funding Opportunities To Support Early-Career Brain Tumor Scientists

  December 1, 2015

   · 

  2 min read
• Business

  Regen BioPharma Attracts Top Researchers To Scientific Advisory Board

  December 1, 2015

   · 

  3 min read
• Drug Development

  PhaseBio Receives FDA Orphan Drug Designation For Vasomera (PB1046) For The Treatment Of Cardiomyopathy Associated With Dystrophinopathies

  December 1, 2015

   · 

  4 min read